Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

APGE

Apogee Therapeutics Inc

133.96

Jul 14 • 03:59PM ET +0.14 (0.10%)

134.50

Aftermarket • 05:47PM ET +0.54 (0.40%)

Healthcare Biotechnology USA Large NASD

Peers: KYMR BMRN MDGL RYTM VKTX KRYS NUVL AXSM INCY NBIX

| Held by: XBI IWM VTI IWO IBB VXF SCHA VTWO ITOT VHT

Scroll to Statements

Index	RUT
Market Cap	10.07B
Enterprise Value	9.02B
Income	-274.62M
Sales	0.00M
Book/sh	16.77
Cash/sh	14.10
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	261
IPO	Jul 14, 2023

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	7.99
P/C	9.50
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	32.59
Current Ratio	32.59
Debt/Eq	0.01
LT Debt/Eq	0.00
Option/Short	Yes / Yes

EPS (ttm)	-4.33
EPS next Y	-5.54
EPS next Q	-1.07
EPS this Y	-5.26%
EPS next Y	-24.72%
EPS next 5Y	-12.96%
EPS past 3/5Y	-75.11% -
Sales past 3/5Y	- -
EPS Y/Y TTM	-22.17%
Sales Y/Y TTM	-
EPS Q/Q	-11.87%
Sales Q/Q	-
Earnings	May 11 BMO
EPS/Sales Surpr.	0.83% -

Insider Own	24.30%
Insider Trans	-10.05%
Inst Own	75.53%
Inst Trans	-19.25%
ROA	-27.35%
ROE	-28.47%
ROIC	-21.78%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	8.04%
SMA50	34.92%
SMA200	73.94%
Trades

Shs Outstand	61.40M
Shs Float	56.91M
Short Float	9.07%
Short Ratio	2.04
Short Interest	5.16M
52W High	133.88 0.06%
52W Low	34.34 290.10%
Volatility	0.34% 1.73%
ATR (14)	2.74
RSI (14)	81.40
Beta	0.34
Rel Volume	0.54
Avg Volume	2.53M
Volume	1,364,183

Perf Week	0.31%
Perf Month	49.68%
Perf Quarter	54.44%
Perf Half Y	71.77%
Perf YTD	77.48%
Perf Year	244.55%
Perf 3Y	530.99%
Perf 5Y	-
Perf 10Y	-
Recom	2.60
Target Price	132.79
Prev Close	133.82
Price	133.96
Change	0.10%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)